| Global geographic trends in antimicrobial resistance: the role of international travel |
36 |
| Severe dengue in travellers: pathogenesis, risk and clinical management |
30 |
| Severe yellow fever in Brazil: clinical characteristics and management |
19 |
| Dengue infection in international travellers visiting Bali, Indonesia |
15 |
| Dengue, Zika and chikungunya during pregnancy: pre- and post-travel advice and clinical management |
15 |
| Infectious disease implications of large-scale migration of Venezuelan nationals |
15 |
| Measuring mobility, disease connectivity and individual risk: a review of using mobile phone data and mHealth for travel medicine |
14 |
| Imported dengue in Spain: a nationwide analysis with predictive time series analyses |
14 |
| Factors Affecting Pre-Travel Health Seeking Behaviour and Adherence to Pre-Travel Health Advice: A Systematic Review |
13 |
| Mental health needs and services for migrants: an overview for primary care providers |
13 |
| Japanese encephalitis: the vectors, ecology and potential for expansion |
12 |
| Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers |
12 |
| Ebola virus outbreak in North Kivu and Ituri provinces, Democratic Republic of Congo, and the potential for further transmission through commercial air travel |
11 |
| Evaluation of rapid diagnostic tests and conventional enzyme-linked immunosorbent assays to determine prior dengue infection |
9 |
| Improving access and provision of pre-travel healthcare for travellers visiting friends and relatives: a review of the evidence |
9 |
| Non-communicable diseases in migrants: an expert review |
9 |
| Tafenoquine for travelers ' malaria: evidence, rationale and recommendations |
9 |
| Zika in travellers 1947-2017: a systematic review |
8 |
| Climate change impact on migration, travel, travel destinations and the tourism industry |
7 |
| Dengue virus not detected in human semen |
7 |
| Perceptions of rabies risk: a survey of travellers and travel clinics from Canada, Germany, Sweden and the UK |
6 |
| Susceptibility to measles in migrant population: implication for policy makers |
6 |
| High-dose or multi-day praziquantel for imported schistosomiasis? A systematic review |
6 |
| Recent and historical trends in the epidemiology of Japanese encephalitis and its implication for risk assessment in travellers |
6 |
| Tafenoquine and G6PD: a primer for clinicians |
6 |
| Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis |
6 |
| Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997-2017 |
6 |
| Fractional-dose yellow fever vaccination: an expert review |
6 |
| Association between air travel and importation of chikungunya into the USA |
5 |
| Exposure to air pollution is associated with adverse cardiopulmonary health effects in international travellers |
5 |
| Travel and biologic therapy: travel-related infection risk, vaccine response and recommendations |
5 |
| Patient care without borders: a systematic review of medical and surgical tourism |
5 |
| Business travel-associated illness: a GeoSentinel analysis |
5 |
| Use of a multiplex DNA extraction PCR in the identification of pathogens in travelers' diarrhea |
5 |
| Safety of live vaccines on immunosuppressive or immunomodulatory therapy-a retrospective study in three Swiss Travel Clinics |
5 |
| Rifamycin SV-MMX (R) for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria |
5 |
| Geographic expansion of artemisinin resistance |
5 |
| Illness among US resident student travellers after return to the USA: a GeoSentinel analysis, 2007-17 |
4 |
| Surveillance of travel-associated diseases at two referral centres in Marseille, France: a 12-year survey |
4 |
| Chagas disease: comments on the 2018 PAHO Guidelines for diagnosis and management |
4 |
| A summary of the imported cases of Chikungunya fever in Japan from 2006 to June 2016 |
4 |
| Mosquito repellents for the traveller: does picaridin provide longer protection than DEET? |
4 |
| Aesthetic journeys: a review of cosmetic surgery tourism |
4 |
| Severe obesity as a barrier to international travel: a qualitative analysis |
4 |
| Antibiotic resistance patterns of Escherichia coli in migrants vs non-migrants: a study of 14 561 urine samples |
4 |
| Protecting the health of medical students on international electives in low-resource settings |
4 |
| Infectious diseases acquired by international travellers visiting the USA |
3 |
| Enteric fever among children: 50 cases in a French tertiary care centre |
3 |
| Travel-associated STI amongst HIV and non-HIV infected travellers |
3 |
| Standard pre-travel consultation versus shorter consultation combined with smartphone support: a randomized controlled trial |
3 |
